Loading...
Cingulate Inc.
CING•NASDAQ
Healthcare
Biotechnology
$5.10
$-0.08(-1.54%)
Cingulate Inc. (CING) Financial Performance & Income Statement Overview
Review Cingulate Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
31.26%
↑ 31.26%
Net Income Growth
33.95%
↑ 33.95%
Operating Cash Flow Growth
-22.73%
↓ 22.73%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-473.25%
↓ 473.25%
ROIC
-95.90%
↓ 95.90%
Cingulate Inc. (CING) Income Statement & Financial Overview
Review Cingulate Inc.'s (CING) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $3.28B | $3.21B |
| Gross Profit | $0.00 | $0.00 | -$3.28B | -$3.21B |
| Gross Profit Ratio | ||||
| R&D Expenses | $2.22B | $4.33M | $1.43M | $1.88M |
| SG&A Expenses | $1.48B | $1.88M | $1.85M | $1.33M |
| Operating Expenses | $3.71B | $6.21M | $3.28M | $3.21M |
| Total Costs & Expenses | $0.00 | $6.21M | $3.28M | $3.21M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | -$96.66M | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $160302.00 | $6.56B | -$6.41B |
| EBITDA | $0.00 | -$5.97M | -$3.12M | -$3.04M |
| EBITDA Ratio | ||||
| Operating Income | $0.00 | -$6.21M | -$6.56B | -$3.21M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $0.00 | $76510.00 | $3.33B | -$3497.00 |
| Income Before Tax | -$3.80B | -$6.13M | -$3.23B | -$3.21M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$3.80B | -$6.13M | -$3.23B | -$3.21M |
| Net Income Ratio | ||||
| EPS | -$1.04 | -$3.47 | -$1.83 | -$5.47 |
| Diluted EPS | -$1.04 | -$3.47 | -$1.83 | -$5.47 |
| Weighted Avg Shares Outstanding | $3.65B | $3.40M | $1.77M | $586312.00 |
| Weighted Avg Shares Outstanding (Diluted) | $3.65B | $3.40M | $1.77M | $586312.00 |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan